ATE303063T1 - Synthetische analoge des ecteinascidin-743 - Google Patents
Synthetische analoge des ecteinascidin-743Info
- Publication number
- ATE303063T1 ATE303063T1 AT99948484T AT99948484T ATE303063T1 AT E303063 T1 ATE303063 T1 AT E303063T1 AT 99948484 T AT99948484 T AT 99948484T AT 99948484 T AT99948484 T AT 99948484T AT E303063 T1 ATE303063 T1 AT E303063T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted
- unsubstituted
- co2h
- nhc
- alkynyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/165,892 US6124292A (en) | 1998-09-30 | 1998-09-30 | Synthetic analogs of ecteinascidin-743 |
PCT/US1999/022405 WO2000018233A1 (en) | 1998-09-30 | 1999-09-30 | Synthetic analogs of ecteinascidin-743 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE303063T1 true ATE303063T1 (de) | 2005-09-15 |
Family
ID=22600906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99948484T ATE303063T1 (de) | 1998-09-30 | 1999-09-30 | Synthetische analoge des ecteinascidin-743 |
Country Status (13)
Country | Link |
---|---|
US (3) | US6124292A (de) |
EP (1) | EP1117297B1 (de) |
JP (1) | JP4638985B2 (de) |
AT (1) | ATE303063T1 (de) |
AU (1) | AU765439B2 (de) |
CA (1) | CA2345297C (de) |
DE (1) | DE69927039T2 (de) |
DK (1) | DK1117297T3 (de) |
ES (1) | ES2249028T3 (de) |
HK (1) | HK1039727B (de) |
MX (1) | MXPA01003339A (de) |
NZ (1) | NZ510734A (de) |
WO (1) | WO2000018233A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR200003470T2 (tr) * | 1998-05-11 | 2001-06-21 | Pharama Mar, S.A. | Ecteinascidin 743 Metabolitleri |
US6124292A (en) * | 1998-09-30 | 2000-09-26 | President And Fellows Of Harvard College | Synthetic analogs of ecteinascidin-743 |
MY164077A (en) * | 1999-05-13 | 2017-11-30 | Pharma Mar Sa | Compositions and uses of et743 for treating cancer |
AR035842A1 (es) * | 1999-05-14 | 2004-07-21 | Pharma Mar Sa | Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo |
GB9918178D0 (en) * | 2000-05-15 | 1999-10-06 | Pharma Mar Sa | Synthetic methods |
US6686470B2 (en) * | 2000-01-19 | 2004-02-03 | The Trustees Of Columbia University In The City Of New York | Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
WO2001058905A1 (en) * | 2000-02-11 | 2001-08-16 | President And Fellows Of Harvard College | Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds |
US6815544B2 (en) | 2000-02-11 | 2004-11-09 | President And Fellows Of Harvard College | Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds |
DE60111845T2 (de) * | 2000-04-12 | 2006-04-27 | Pharma Mar, S.A., Tres Cantos | Ecteinaschidin derivate mit antikrebs wirkung |
US7919493B2 (en) * | 2000-04-12 | 2011-04-05 | Pharma Mar, S.A. | Anititumoral ecteinascidin derivatives |
US7420051B2 (en) * | 2000-05-15 | 2008-09-02 | Pharma Mar, S.A. | Synthetic process for the manufacture of an ecteinaschidin compound |
MXPA02011319A (es) * | 2000-05-15 | 2003-06-06 | Pharma Mar Sa | Analogos antitumorales de ecteinascidina 743. |
WO2002040477A2 (en) * | 2000-11-03 | 2002-05-23 | President And Fellows Of Harvard College | Saframycins, analogues and uses thereof |
JP4391083B2 (ja) * | 2000-11-06 | 2009-12-24 | ファルマ・マール・ソシエダード・アノニマ | 効果的な抗腫瘍治療 |
GB0117402D0 (en) * | 2001-07-17 | 2001-09-05 | Pharma Mar Sa | New antitumoral derivatives of et-743 |
GB0119243D0 (en) * | 2001-08-07 | 2001-10-03 | Pharma Mar Sa | Antitumoral analogs of ET-743 |
GB0202544D0 (en) * | 2002-02-04 | 2002-03-20 | Pharma Mar Sa | The synthesis of naturally occuring ecteinascidins and related compounds |
US7183054B2 (en) * | 2003-06-03 | 2007-02-27 | President And Fellows Of Harvard College | Assay for identifying biological targets of polynucleotide-binding compounds |
US20090117176A1 (en) * | 2004-10-26 | 2009-05-07 | Pharma Mar, S.A. Sociedad Unipersonal | Anticancer Treatments |
RU2382647C2 (ru) * | 2004-10-29 | 2010-02-27 | Фарма Мар С.А., Сосьедад Униперсональ | Композиции, содержащие эктинэсайдин и дисахарид |
GB0522082D0 (en) * | 2005-10-31 | 2005-12-07 | Pharma Mar Sa | Formulations |
JP2011520846A (ja) * | 2008-05-16 | 2011-07-21 | ファルマ・マール・ソシエダード・アノニマ | 多発性骨髄腫の治療 |
CA2724325A1 (en) * | 2008-05-16 | 2009-11-19 | Pharma Mar, S.A. | Combination therapy with an antitumor alkaloid |
WO2011048210A1 (en) | 2009-10-22 | 2011-04-28 | Pharma Mar, S.A. | PDGFR-α AS RESPONSE MARKER FOR PM00104 TREATMENT |
CA2800097C (en) | 2010-05-25 | 2019-01-08 | Pharma Mar, S.A. | Synthetic process for the manufacture of ecteinascidin compounds and intermediates |
LT2786753T (lt) | 2010-11-12 | 2019-04-10 | Pharma Mar S.A. | Derinių terapija su antinavikiniu antibiotiku |
CN107522698B (zh) * | 2016-06-20 | 2021-12-28 | 浙江海正药业股份有限公司 | 一种曲贝替定的制备方法及其中间体 |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
US10597378B2 (en) | 2017-09-08 | 2020-03-24 | National Health Research Institutes | Tetrahydroisoquinolines for use as MOR/NOP dual agonists |
CN111518110B (zh) * | 2019-02-01 | 2023-11-03 | 博瑞生物医药(苏州)股份有限公司 | 一种海鞘素化合物及其中间体的制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5937952B2 (ja) | 1977-09-12 | 1984-09-12 | 正 新井 | 抗生物質サフラマイシンa,b,c,d,eおよびその製造法 |
JPS56135486A (en) | 1980-03-26 | 1981-10-22 | Tadashi Arai | Antibiotic saframycin s and its preparative method |
JPS5942382A (ja) * | 1982-09-02 | 1984-03-08 | Yoshitomi Pharmaceut Ind Ltd | サフラシン誘導体 |
JPS6158593A (ja) * | 1984-08-30 | 1986-03-25 | Tadashi Arai | 新規サフラマイシンa誘導体およびその製造法 |
EP0233841A1 (de) * | 1986-02-18 | 1987-08-26 | Arai, Tadashi, Prof. | Chinon-Derivate und Verfahren zu ihrer Herstellung |
US5089273A (en) * | 1986-06-09 | 1992-02-18 | Board Of Trustees Of The University Of Illinois | Ecteinascidins 729, 743, 745, 759A, 759B and 770 |
US5256663A (en) * | 1986-06-09 | 1993-10-26 | The Board Of Trustees Of The University Of Illinois | Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith |
JPS632991A (ja) * | 1986-06-23 | 1988-01-07 | Akinori Kubo | 新規イソキノリン誘導体 |
EP0262085A1 (de) * | 1986-08-15 | 1988-03-30 | Gesellschaft für Biotechnologische Forschung mbH (GBF) | Antibiotika aus Myxococcus |
EP0329606A3 (de) * | 1988-02-12 | 1991-04-03 | Ciba-Geigy Ag | Neue Antibiotika aus Myxococcus |
US5478932A (en) * | 1993-12-02 | 1995-12-26 | The Board Of Trustees Of The University Of Illinois | Ecteinascidins |
US5721362A (en) * | 1996-09-18 | 1998-02-24 | President And Fellows Of Harvard College | Process for producing ecteinascidin compounds |
US6124292A (en) * | 1998-09-30 | 2000-09-26 | President And Fellows Of Harvard College | Synthetic analogs of ecteinascidin-743 |
-
1998
- 1998-09-30 US US09/165,892 patent/US6124292A/en not_active Expired - Lifetime
-
1999
- 1999-09-30 AT AT99948484T patent/ATE303063T1/de active
- 1999-09-30 JP JP2000571761A patent/JP4638985B2/ja not_active Expired - Lifetime
- 1999-09-30 DE DE69927039T patent/DE69927039T2/de not_active Expired - Lifetime
- 1999-09-30 DK DK99948484T patent/DK1117297T3/da active
- 1999-09-30 EP EP99948484A patent/EP1117297B1/de not_active Expired - Lifetime
- 1999-09-30 AU AU61650/99A patent/AU765439B2/en not_active Expired
- 1999-09-30 MX MXPA01003339A patent/MXPA01003339A/es active IP Right Grant
- 1999-09-30 NZ NZ510734A patent/NZ510734A/en not_active IP Right Cessation
- 1999-09-30 CA CA002345297A patent/CA2345297C/en not_active Expired - Lifetime
- 1999-09-30 ES ES99948484T patent/ES2249028T3/es not_active Expired - Lifetime
- 1999-09-30 WO PCT/US1999/022405 patent/WO2000018233A1/en active IP Right Grant
-
2000
- 2000-02-22 US US09/510,315 patent/US6348467B1/en not_active Ceased
-
2002
- 2002-01-24 HK HK02100545.8A patent/HK1039727B/zh not_active IP Right Cessation
-
2003
- 2003-12-17 US US10/738,973 patent/USRE41614E1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP4638985B2 (ja) | 2011-02-23 |
US6348467B1 (en) | 2002-02-19 |
CA2345297A1 (en) | 2000-04-06 |
DK1117297T3 (da) | 2006-01-09 |
USRE41614E1 (en) | 2010-08-31 |
HK1039727A1 (en) | 2002-05-10 |
EP1117297B1 (de) | 2005-08-31 |
EP1117297A4 (de) | 2002-02-27 |
CA2345297C (en) | 2009-12-22 |
DE69927039T2 (de) | 2006-06-22 |
MXPA01003339A (es) | 2002-07-02 |
NZ510734A (en) | 2003-10-31 |
ES2249028T3 (es) | 2006-03-16 |
EP1117297A1 (de) | 2001-07-25 |
HK1039727B (zh) | 2006-01-06 |
WO2000018233A1 (en) | 2000-04-06 |
DE69927039D1 (de) | 2005-10-06 |
AU6165099A (en) | 2000-04-17 |
AU765439B2 (en) | 2003-09-18 |
US6124292A (en) | 2000-09-26 |
JP2002525296A (ja) | 2002-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69927039D1 (de) | Synthetische analoge des ecteinascidin-743 | |
DE60033857D1 (de) | Derivate des N-((Chinolinyl)oxy)-phenyl)-Harnstoffs und des N-((Chinazolinyl)oxy)-phenyl)-Harnstoffs mit Antitumor Aktivität | |
EA200600509A1 (ru) | Соединения пиримидотиофена | |
CY1109283T1 (el) | Παραγωγα βαριολινης ως αντικαρκινικα μεσα | |
CY1113359T1 (el) | Αντι-νεοπλασιακα παραγωγα του et-743 | |
ATE118207T1 (de) | Heterozyklische acylaminodiol-beta-aminosäure- derivate. | |
DE60237652D1 (de) | Variolinderivate und ihre Verwendung als Cytostatika | |
MXPA02012121A (es) | Compuestos antitumorales. | |
BR9709791A (pt) | Intermediários para a síntese de oligonucleotíedeos | |
DE60116855D1 (de) | Oxy- und aminosubstituierte tetrahydrofurylderivate mit antitumoraktivität | |
NO20051037L (no) | Totalsyntese av myriaporoner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1117297 Country of ref document: EP |